Publications & Works

Publication Network
Published journal articles indexed by SCI, SSCI, and AHCI

Evaluation of interleukin-8 levels in the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies

Sensoy L., Atilla A., Gullu Y. T., Gur Vural D., Turgut M., Esen Ş., et al.
MEDICAL MYCOLOGY , vol.62, no.5, 2024 (SCI-Expanded) Sustainable Development identifier identifier identifier

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data

Birtas Atesoglu E., Gulbas Z., UZAY A., ÖZCAN M., ÖZKALEMKAŞ F., Dal M. S., et al.
Hematological Oncology , vol.41, no.4, pp.663-673, 2023 (SCI-Expanded) identifier identifier

A Survey of Chronic Lymphocytic Leukemia Treatment Approaches in Turkey: A Turkish Hematology Network Group Study

GÜVENÇ B., ÖZCAN M. A., SÖNMEZ M., Turgut M., ÜNAL A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

Addressing Multiple Myeloma in Turkey: A Nationwide Survey by the Turkish Hematology Network Group Highlights Opportunities and Challenges

GÜVENÇ B., ÖZCAN M. A., TOPRAK S. K., Turgut M.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023 (SCI-Expanded) identifier

Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study

Landgren O., Weisel K., Rosinol L., Touzeau C., Turgut M., Hajek R., et al.
BRITISH JOURNAL OF HAEMATOLOGY , vol.198, no.6, pp.988-993, 2022 (SCI-Expanded) identifier identifier identifier

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis

Capra M., Martin T., Moreau P., Baker R., Pour L., Min C., et al.
HAEMATOLOGICA , vol.107, no.6, pp.1397-1409, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia

Pratz K. W., Panayiotidis P., Recher C., Wei X., Jonas B. A., Montesinos P., et al.
BLOOD CANCER JOURNAL , vol.12, no.4, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier

Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting

EŞKAZAN A. E., ALİ R., Alnigenis E., Ayyildiz O., Haznedaroglu I., Kirkizlar O., et al.
EXPERT REVIEW OF HEMATOLOGY , vol.15, no.2, pp.97-106, 2022 (SCI-Expanded) identifier identifier identifier

Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study

KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.32, no.4, pp.209-213, 2022 (SCI-Expanded) identifier identifier identifier

Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study

ÇINAR O. E., GÖKER H., FİDAN K., Aydin O., Pashayev T., MALKAN Ü. Y., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.3, pp.152-159, 2022 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

Efficacy and Safety of Eltrombopag Combined with Cyclosporine As First-Line Therapy in Adults with Severe Acquired Aplastic Anemia: Results of the Interventional Phase 2 Single-Arm Soar Study

Vallejo C., Jang J. H., Finelli C., Montano Figueroa E., Norasetthada L., Calado R. T., et al.
BLOOD , vol.138, 2021 (SCI-Expanded) identifier

Evaluation of Hepatitis B screening and reactivation in patients receiving rituximab containing chemotherapy: A single-centre study

Bozkurt İ., Cerik H. O., Kır S., Ustaoğlu Dede M., Turgut M., Esen Ş.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , vol.75, 2021 (SCI-Expanded) Creative Commons License Sustainable Development identifier identifier identifier

Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study

Stilgenbauer S., Bosch F., Ilhan O., Kisro J., Mahe B., Mikuskova E., et al.
BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2, pp.325-338, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier

Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia

ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.21, no.3, pp.147-153, 2021 (SCI-Expanded) identifier identifier identifier

Evaluation of Cardiac Repolarization in the Randomized Phase 2 Study of Intermediate- or High-Risk Smoldering Multiple Myeloma Patients Treated with Daratumumab Monotherapy

Chari A., Munder M., Weisel K., Jenner M., Bygrave C., Petrucci M. T., et al.
ADVANCES IN THERAPY , vol.38, no.2, pp.1328-1341, 2021 (SCI-Expanded) Creative Commons License identifier identifier identifier

Clinical Course of Covid-19 in Hematological Disorders

Atay M. H., Okuyucu M., Güllü Y. T., Tuna N. T., Bilek H. C., Tanyel E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.3, pp.153-160, 2021 (SCI-Expanded) identifier identifier identifier

Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey

SOYER N., ALİ R., Turgut M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.3, pp.1033-1042, 2021 (SCI-Expanded) identifier identifier identifier identifier

WHO 2016 Prefibrotic Myelofibrosis in the Patients with WHO 2008 Essential Thrombocythemia

Aktimur S. H., Baycelebi D., Gunes A. K., Yıldız L., Turgut M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.3, pp.139-145, 2021 (SCI-Expanded) identifier identifier identifier

A rare side effect: Eltrombopag associated hyperpigmentation

Atay H., Kelkitli E., Turgut M.
Giornale Italiano di Dermatologia e Venereologia , vol.155, no.6, pp.803-804, 2020 (SCI-Expanded) identifier identifier

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Bekoz H., ÖZBALAK M. M., Karadurmus N., PAYDAŞ S., Turker A., TOPTAŞ T., et al.
ANNALS OF HEMATOLOGY , vol.99, no.11, pp.2565-2576, 2020 (SCI-Expanded) identifier identifier identifier

Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis

Kater A., Panagiotis P., Aktan M., ARSLAN Ö., DEMİRKAN F., Enggaard L., et al.
LEUKEMIA & LYMPHOMA , vol.61, pp.113-115, 2020 (SCI-Expanded) identifier

Obinutuzumab plus fludarabine and cyclophosphamide in previously untreated, fit patients with chronic lymphocytic leukemia: a subgroup analysis of the GREEN study

Bosch F., Cantin G., Cortelezzi A., Knauf W., Tiab M., Turgut M., et al.
LEUKEMIA , vol.34, no.2, pp.441-450, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience

GÖKER H., Ciftciler R., DEMİROĞLU H., Turgut M., SAYINALP N., Haznedaroglu I. C., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.1, 2020 (SCI-Expanded) identifier identifier identifier

Efficacy of the Combination of Venetoclax and Azacitidine in Elderly of Frail Relapsed/Refractory Patients with Acute Myeloid Leukemia, First Multi-Institutional Real World Experience from Turkey

Aktimur S. H., Gunes A. K., AKIDAN O., KARATAŞ A., Turgut M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.4, pp.213-221, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier

Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

BÜYÜKAŞIK Y., ALİ R., Turgut M., SAYDAM G., Güçlü Y. S., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.37, no.3, pp.177-185, 2020 (SCI-Expanded) Creative Commons License identifier identifier identifier identifier

CD34+hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation

ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., Turgut M., AKSU S., SAYINALP N., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.50, no.8, pp.1851-1856, 2020 (SCI-Expanded) identifier identifier identifier identifier

Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or Cytopenia

Ozdemir Z. N., Ilhan O., Ozet G., Falay M., Yenerel M., Tuglular T., et al.
CLINICAL LABORATORY , vol.66, no.9, pp.1709-1715, 2020 (SCI-Expanded) identifier identifier identifier

What is the role of the decrease in immunoglobulin level after the first cycle in patient with multiple myeloma?

GÖKER H., Kelkitli E., Turgut M.
AMERICAN JOURNAL OF HEMATOLOGY , vol.94, 2019 (SCI-Expanded) identifier

Mantle cell lymphoma: a Turkish Multi-Center Study

Okay M., Meletli O., Kelkitli E., MALKAN Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.
JOURNAL OF BUON , vol.24, no.5, pp.2084-2089, 2019 (SCI-Expanded) identifier identifier identifier

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Younes A., Sehn L. H., Johnson P., Zinzani P. L., Hong X., Zhu J., et al.
JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15, pp.1285-1306, 2019 (SCI-Expanded) Creative Commons License identifier identifier identifier

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

O'Connor O. A., ÖZCAN M., Jacobsen E. D., Roncero J. M., Trotman J., Demeter J., et al.
JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.8, pp.613-624, 2019 (SCI-Expanded) identifier identifier identifier

A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience

Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., ÖZKOCAMAN V., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.4, pp.230-237, 2019 (SCI-Expanded) identifier identifier identifier identifier

Impact of Fluorescent In Situ Hybridization Aberrations and CLLU1 Expression on the Prognosis of Chronic Lymphocytic Leukemia: Presentation of 156 Patients from Turkey

Abur Ü., Ogur G., Akar Ö. S., Altundağ E., Aymelek H. S., Özatlı D., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.35, no.1, pp.61-65, 2018 (SCI-Expanded) Creative Commons License identifier identifier identifier

Polycythemia vera: diagnosis, clinical course, and current management

BÜYÜKAŞIK Y., ALİ R., Çırak C. R., Turgut M., Güçlü Y. S., SAYDAM G.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.48, no.4, pp.698-710, 2018 (SCI-Expanded) identifier identifier identifier identifier

Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma

Younes A., Salles G., Martinelli G., Bociek R. G., Barrigon D. C., Barca E. G., et al.
HAEMATOLOGICA , vol.102, no.12, pp.2104-2112, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study

Lugtenburg P., Avivi I., Berenschot H., Ilhan O., Marolleau J. P., Nagler A., et al.
HAEMATOLOGICA , vol.102, no.11, pp.1913-1922, 2017 (SCI-Expanded) Sustainable Development identifier identifier identifier

Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders

AKSU S., Ayyildiz O., Etgul S., GÖKER H., Gunes G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.12-19, 2016 (SCI-Expanded) Creative Commons License identifier identifier

The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases

Aktimur S. H., MALKAN Ü. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., Kelkitli E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.3, pp.153-158, 2016 (SCI-Expanded) Creative Commons License identifier identifier

Safety and Efficacy of Ankaferd Hemostat (ABS) in the Chemotherapy-Induced Oral Mucositis

Atay M. H., Arslan N. A., Aktimur S., Buyukkaya P., Kelkitli E., Turgut M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.3, pp.166-171, 2015 (SCI-Expanded) Creative Commons License identifier identifier

Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML

MALKAN Ü. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.25, no.4, pp.215-221, 2015 (SCI-Expanded) Creative Commons License identifier identifier

Papillophlebitis associated with the use of oral contraceptive: a case report

Yucel Ö., GÜNGÖR İ., Gul A., Turgut M., Arıtürk N.
GYNECOLOGICAL ENDOCRINOLOGY , vol.31, no.8, pp.601-603, 2015 (SCI-Expanded) identifier identifier identifier

An Unusual Cause of Thigh Swelling: Extramedullary Myeloid Tumor

Atay M. H., Kelkitli E., Buyukkaya P., Ekiz K., Yıldız L., Turgut M.
TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.2, pp.201-202, 2014 (SCI-Expanded) Creative Commons License identifier identifier identifier

Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio

Kelkitli E., Atay H., Cilingir F., Guler N., Terzi Y., Özatlı D., et al.
ANNALS OF HEMATOLOGY , vol.93, no.5, pp.841-846, 2014 (SCI-Expanded) identifier identifier identifier

The relationship of t helper-2 pathway components interleukin-4, interleukin-10, immunoglobulin e, and eosinophils with prognostic markers in non-hodgkin lymphoma: A case-control study Yardımcı T Lenfosit-2 Yolağı Bileşenlerinden İnterlökin-4, İnterlökin-10, İmmünglobülin E ve Eozinofiller’in Hodgkin-Dışı Lenfoma’nın Prognostik Belirteçleri ile Olan İlişkisi-Kontrollü Klinik Çalışma

Güler N., Kelkitli E., Atay H., Erdem D., Alaçam H., Bek Y., et al.
Turkish Journal of Hematology , vol.31, no.4, pp.381-386, 2014 (SCI-Expanded) Creative Commons License identifier identifier identifier

Ibrutinib: From Molecule to Medicine

Ayyildiz O., DEMİRKAN F., GÖKER H., HAZNEDAROĞLU İ. C., Ilhan O., KAYNAR L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.4-14, 2014 (SCI-Expanded) Creative Commons License identifier

Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients

ŞAHİN F., SAYDAM G., Comert M., Uz B., Güçlü Y. S., Turan E., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.4, pp.351-358, 2013 (SCI-Expanded) Creative Commons License identifier identifier

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience

GÖKER H., Ozdemir E., Uz B., BÜYÜKAŞIK Y., Turgut M., Serefhanoglu S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.49, no.3, pp.590-599, 2013 (SCI-Expanded) identifier identifier identifier

EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate

Uz B., BÜYÜKAŞIK Y., Atay H., Kelkitli E., Turgut M., Bektas O., et al.
HEMATOLOGY , vol.18, no.5, pp.247-252, 2013 (SCI-Expanded) identifier identifier identifier

Prognostic impact of LIM domain only 2 (LMO2) in chronic myelogenous leukaemia

Atay M. H., Özatlı D., Kelkitli E., Yıldız L., Turgut M., Guler N., et al.
HISTOPATHOLOGY , vol.63, no.2, pp.293-294, 2013 (SCI-Expanded) identifier identifier identifier

Presentation of mantle cell lymphoma with symptoms of prostatism

Atay M. H., Kelkitli E., Alici Ö., Çilingir F., Turgut M.
Polskie Archiwum Medycyny Wewnetrznej , vol.123, no.11, pp.643-644, 2013 (SCI-Expanded) Creative Commons License identifier identifier

Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study

BÜYÜKAŞIK Y., ACAR K., Kelkitli E., Uz B., Serefhanoglu S., Ozdemir E., et al.
ACTA HAEMATOLOGICA , vol.130, no.3, pp.199-205, 2013 (SCI-Expanded) identifier identifier identifier

The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia

AKSU S., ŞAHİN F., Uz B., Güçlü Y. S., Atay H., Kelkitli E., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, pp.8-14, 2012 (SCI-Expanded) Creative Commons License identifier

Clinical and epidemiological features of Turkish children with 2009 pandemic influenza A (H1N1) infection: Experience from multiple tertiary paediatric centres in Turkey

ÇİFTCİ E., Tuygun N., ÖZDEMİR H., Tezer H., Sensoy G., Devrim I., et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , vol.43, no.11-12, pp.923-929, 2011 (SCI-Expanded) Sustainable Development identifier identifier identifier

Topical Ankaferd Bloodstopper in the management of critical bleedings due to hemorrhagic diathesis Hemorajik diyatez varlıǧında gelişlen kritik kanamalarda Topikal Ankaferd Bloodstopper uygulamaları

Turgut M., Tutkun F., Celebi N., Muğlalı M., HAZNEDAROĞLU İ. C., GÖKER H.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , vol.21, no.3, pp.160-165, 2011 (SCI-Expanded) Creative Commons License identifier

Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy

Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH , vol.34, no.12, 2010 (SCI-Expanded) identifier identifier

Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy

Bektas A., ÇAKAR B., Ustaoğlu Dede M., Turgut M., Bakir T.
TURKISH JOURNAL OF GASTROENTEROLOGY , vol.21, no.1, pp.73-74, 2010 (SCI-Expanded) Sustainable Development identifier identifier

Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors

Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY , vol.88, no.7, pp.667-671, 2009 (SCI-Expanded) identifier identifier

In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract

AKÇELİK N., AKÇELİK M., HAZNEDAROĞLU İ. C., GÖKER H., Turgut M., AKSU S., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , vol.29, no.2, pp.410-415, 2009 (SCI-Expanded) Sustainable Development identifier

High ratio of Duffy (a+ b+) phenotype in patients with Multiple Myeloma compared to healthy controls

Guler N., Turgut M., Özatlı D., Turgut Y., Gokce A. K., Koc S., et al.
HEMATOLOGICAL ONCOLOGY , vol.27, no.1, pp.50-51, 2009 (SCI-Expanded) identifier identifier

Hemostatic Efficacy of Ankaferd Blood Stopper (R) in a Swine Bleeding Model

Bilgili H., Kosar A., Kurt M., Onal I. K., GÖKER H., ÖZDEMİR Ö., et al.
MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.3, pp.165-169, 2009 (SCI-Expanded) identifier identifier

Relation between hemostatic parameters and prognostic/predictive factors in breast cancer

Yigit E., Goenuellue G., Yuecel I., Turgut M., Erdem D., ÇAKAR B.
EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.19, no.8, pp.602-607, 2008 (SCI-Expanded) Sustainable Development identifier identifier

A prospective study of etiology of childhood acute bacterial meningitis, Turkey

CEYHAN M., Yildirim I., Balmer P., Borrow R., Dikici B., Turgut M., et al.
Emerging Infectious Diseases , vol.14, no.7, pp.1089-1096, 2008 (SCI-Expanded) Creative Commons License identifier identifier

Effects of postnatal formaldehyde exposure on pyramidal cell number, volume of cell layer in hippocampus and hemisphere in the rat: A stereological study

Sarsilmaz M., Kaplan S., Songur A., Colakoglu S., Aslan H., Tunc A. T., et al.
BRAIN RESEARCH , vol.1145, pp.157-167, 2007 (SCI-Expanded) identifier identifier

Inhibitory effect of pinealectomy on the development of cerebellar granule cells in the chick: A stereological study

Tunc A. T., Aslan H., Turgut M., Ekici F., Odaci E., Kaplan S.
BRAIN RESEARCH , vol.1138, pp.214-220, 2007 (SCI-Expanded) identifier identifier

Effects of Ca2+channel blocker verapamil on tissue regeneration in a lizard tail autotomy model: a biochemical and histological study

Turgut M., Koca Y. B., Kaplan S., Metin K., Uzum N., SOYLU E., et al.
AMPHIBIA-REPTILIA , vol.28, no.1, pp.7-15, 2007 (SCI-Expanded) Creative Commons License identifier

Effect of pinealectomy on the morphology of the chick cervical spinal cord: A stereological and histopathological study

Turgut M., Tunc A. T., Aslan H., Yazici A. C., Kaplan S.
BRAIN RESEARCH , vol.1129, no.1, pp.166-173, 2007 (SCI-Expanded) identifier identifier

Effects of formaldehyde exposure on granule cell number and volume of dentate gyrus: A histopathological and stereological study

Aslan H., Songur A., Tunc A. T., Ozen O. A., Bas O., Yagmurca M., et al.
BRAIN RESEARCH , vol.1122, pp.191-200, 2006 (SCI-Expanded) identifier identifier

Paroxysmal nocturnal hemoglobinuria clone in patients with myelodysplastic syndrome [5]

Yenerel M. N., Diz-Kucukkaya R., Besisik S., Aktan M., Nalcaci M., Dincol G., et al.
American Journal of Hematology , vol.68, no.1, pp.64-65, 2001 (SCI-Expanded) identifier identifier
Articles Published in Other Journals

Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia

SAYDAM G., ÜNAL A., HAZNEDAROĞLU İ. C., HACİHANİFİOĞLU A., MEHTAP Ö., KURTOĞLU E., et al.
Future Medicine Ltd , vol.11, 2022 (Peer-Reviewed Journal) identifier

Abciximab-induced thrombocytopenia: Correct management

Kelkitli E., Odabaşi Giden A., Denız Kürekçi D., Turgut M.
Journal of Experimental and Clinical Medicine (Turkey) , vol.39, no.2, pp.581-583, 2022 (Scopus) Creative Commons License identifier

Multipl Miyelomda Prognostik Faktörler ve Yeni Uluslararası Evreleme Sistemi

Aydın Ö., KELKİTLİ E., TURGUT M.
Turkiye Klinikleri Hematology - Special Topics , pp.1-4, 2019 (Peer-Reviewed Journal)

Multipl Miyelom Epidemiyolojisi ve Genetiği, Tanısı ve Tedaviye Yanıt Kriterleri

MELETLİ Ö., KELKİTLİ E., TURGUT M.
Turkiye Klinikleri Hematology-Special Topics , 2019 (Peer-Reviewed Journal)

Multipl Miyelomda Yeni İlaçlar ve Klinik Çalışmalar

KELKİTLİ E., TURGUT M.
urkiye Klinikleri Hematology-Special Topics , pp.59-64, 2019 (Peer-Reviewed Journal)

HAVAYOLUNU TIKAYAN İZOLE DİL KÖKÜYERLEŞİMLİ LENFOMAISOLATED LYMPHOMA WITH TONGUE BASELOCALISATION OBSTRUCTING AIRWAY

SANCAKTAR M. E., ÇELEBİ M., BAKIRTAŞ M., TURGUT M.
ENTcase , vol.4, no.4, pp.126-130, 2018 (Peer-Reviewed Journal)

Tüylü Hücreli Lösemili HastalarınKlinik Özellikleri ve Tedavi Sonuçları:Tek Merkez Deneyimi

KELKİTLİ E., MELETLİ Ö., TURGUT M.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.1, no.3, pp.72-76, 2017 (Non Peer-Reviewed Journal)

Hodgkin’s lymphoma transformation of CLL/ SLL: case report and review of the literature

GÜN S., ATAY M. H., TURGUT M., YILDIZ L.
Clinical and Diagnostic Pathology , vol.1, no.3, 2017 (Peer-Reviewed Journal)

Akut Promyelositik Lösemi Tanı ve Tedavi

AKTİMUR S. H., KELKİTLİ E., TURGUT M.
Hematolog , vol.6, no.2, pp.214-223, 2016 (Non Peer-Reviewed Journal)

Paterson-Kelly syndrome in a patient with celiac disease

Buyukkaya P., Aslan N. A., Aktimur S. H., Turan S., Atay H., GÜN S., et al.
Journal of Experimental and Clinical Medicine (Turkey) , vol.33, no.3, pp.167-169, 2016 (Scopus) identifier

RDW is a Novel Prognostic Parameter in Diffuse Large B Cell Lymphoma in the Rituximab Era

FATİH T., YASEMİN K., YILMAZ B., AHMET SİYAR E., GÜNEY Y., BEK Y., et al.
Jacobs Journal of Biomarkers , vol.1, no.2, pp.1-5, 2015 (Non Peer-Reviewed Journal)

Attention! Cardiac tamponade may be caused by underlying Castleman's disease

Atay H., Kelkitli E., Okuyucu M., Yıldız L., Turgut M.
Asian Cardiovascular and Thoracic Annals , vol.23, no.4, pp.455-457, 2015 (Scopus) identifier identifier

Mantle cell lymphoma mimicking rectal carcinoma

KELKİTLİ E., ATAY M. H., YILDIZ L., BEKTAŞ A., TURGUT M.
Case Report of Hematology , 2014 (Peer-Reviewed Journal) identifier

A tuberculosis case mimicking lymphoma

ATAY M. H., KELKİTLİ E., TURGUT M.
Pan African Medical Journal , vol.17, 2014 (Scopus) identifier identifier

Effect of LIM domain only LMO2 protein expression on survival in multiple myeloma patients

KELKİTLİ E., ATAY M. H., YILDIZ L., TURGUT M.
Indıan Journal Of Research , vol.2, no.8, pp.59-61, 2013 (Non Peer-Reviewed Journal)

Kronik Miyeloproliferatif Hastalıklarda JAK2V617F Mutasyonu

DEMİR A. K., ATAY M. H., KELKİTLİ E., TURGUT KURT Y., ÖZATLI D., TURGUT M.
Journal of Contemporary Medicine , vol.3, no.2, pp.101-107, 2013 (Peer-Reviewed Journal)

Incidence of the JAK2V617F Mutation in Chronic Myeloproliferative Disorders

DEMİR A. K., ATAY M. H., KELKİTLİ E., KURT Y., ÖZATLI D., TURGUT M.
Journal of Contemporary Medicine , pp.101-107, 2013 (Peer-Reviewed Journal)

Primary ovarian Lymphoma detected during tubal ligation

Kelkitli E., Atay M. H., YILMAZ B., Yıldız L., Turgut M.
Ondokuz Mayis Universitesi Tip Dergisi , vol.30, no.2, pp.197-199, 2013 (Scopus) Creative Commons License identifier

Multiple Myeloma Patobiyolojisi

KELKİTLİ E., TURGUT M.
Turkiye Klinikleri J Hem Onc-Special Topics , pp.4-9, 2013 (Peer-Reviewed Journal)

The Impact of Bone Marrow LMO2 Lim Domain Only2 Protein Expressions on the Clinical Course of Plasma Cell Myeloma

KELKİTLİ E., ATAY M. H., YILDIZ L., TURGUT M.
Indian Journal Of Research , pp.33-35, 2013 (Peer-Reviewed Journal)

Hematolojik Hastalıklarda Splenektomi Tek Merkez Deneyimi

GÖKREM M., ATAY M. H., KELKİTLİ E., BÜYÜKKAYA P., ÖZATLI D., GÜLER N., et al.
Journal of Experimental and Clinical Medicine , vol.29, pp.276-279, 2012 (Scopus) identifier

Splenectomy in haematological diseases; Single center experience Hematolojik hastaliklarda splenektomi; tek merkez deneyimi

Görkem M., Atay M. H., Kelkitli E., Büyükkaya P., Özatlı D., Güler N., et al.
Ondokuz Mayis Universitesi Tip Dergisi , vol.29, no.4, pp.276-279, 2012 (Scopus) Creative Commons License identifier

Effects Of Pınealectomy On Morphologıcal Features Of Blood Vessel In Chıcken An Electron Mıcroscopıc And Stereologıcal Study

TURGUT M., KAPLAN S., ALTUNKAYNAK B. Z., ÜNAL D.
JOURNAL OF EXPERIMENTAL AND CLINICAL MEDICINE , vol.29, pp.112-118, 2012 (Peer-Reviewed Journal)

Akut Miyeloid Lösemide Prognostik Faktörler

KELKİTLİ E., ATAY M. H., TURGUT M.
Turkiye Klinikleri J Hem Onc-Special Topics , 2010 (Non Peer-Reviewed Journal)

Akut myeloid lösemide prognostik faktörler

KELKİTLİ E., ATAY M. H., TURGUT M.
Journal of Hematology-Oncology Special Topics , vol.3, no.2, pp.31-34, 2010 (Non Peer-Reviewed Journal)

Effects of pinealectomy on morphological features of blood vessel in chicken: An electron microscopic and stereological study

Turgut M., Kaplan S., Burçin Ünal Z., Zuhal Altunkaynak B., Un̈al D., Şahin B., et al.
Journal of Experimental and Clinical Medicine (Turkey) , vol.26, no.3, pp.112-118, 2009 (Scopus) Creative Commons License identifier

The importance of hepatitis B prophylaxis in health care workers [3]

Kelkitli E., Yilmaz B., Karaoǧlanoǧlu M., Turgut M.
Turkish Journal of Gastroenterology , vol.17, no.3, pp.244-245, 2006 (Scopus) identifier identifier

Clinical and microbial features of the episodes of febrile neutropenia in acute leukemia patients Akut lösemili hastalarda febril nötropeni ataklarinin klinik ve mikrobiyolojik özellikleri

Çelebi H., Turgut M., Yücel I.
Ondokuz Mayis Universitesi Tip Dergisi , vol.20, no.4, pp.167-171, 2003 (Scopus) identifier

Pulmonary tuberculosis associated with autoimmune hemolytic anemia: An unusual presentation

Turgut M., Uzun O., Kelkitli E., Özer O.
Turkish Journal of Haematology , vol.19, no.4, pp.477-480, 2002 (Scopus) identifier identifier
Refereed Congress / Symposium Publications in Proceedings

Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Zeidan A. M., Ando K., Rauzy O., Turgut M., Wang M., Cairoli R., et al.
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, vol.140, pp.2063-2065 identifier

Treatment Responses in Advanced Age Refractory/Relapsed Diffuse Large B-Cell Lymphoma Patients

ATAY M. H., ODABAŞI GİDEN A., DENİZ D., KELKİTLİ E., TURGUT M.
7th National Blood and Bone Marrow Transplantation Congress, İstanbul, Turkey, 19 May 2022, vol.32, pp.19

Effect of COVID-19 Infection on Patients with Acute Myeloid Leukemia Receiving Treatment

ATAY M. H., ODABAŞI GİDEN A., DENİZ D., KELKİTLİ E., TURGUT M.
7th National Blood and Bone Marrow Transplantation Congress, İstanbul, Turkey, 19 May 2022, vol.92, pp.21

Testi ste Nadi r Bi r Bulgu: Ekstramedüller M yeloi d Tümör

ATAY M. H., ODABAŞI GİDEN A., DENİZ D., KELKİTLİ E., TURGUT M.
8. karadeniz hematoloji kongresi, Samsun, Turkey, 30 June 2022

Karın Içi Hematomun Nadir Nedeni : Fibrinojen eksikliği

ATAY M. H., ODABAŞI GİDEN A., DENİZ D., KELKİTLİ E., TURGUT M.
8. karadeniz hematoloji kongresi, Samsun, Turkey, 30 June 2022

EVALUATION OF THE FREQUENCY OF ARTERIAL AND VENOUS THROMBOSIS AND PREDISPOSING FACTORS IN PATIENTS USING ELTROMBOPAG

Kürekçi D. D., İŞEVİ M., KELKİTLİ E., TURGUT M.
Hematology, Transfusion and Cell Therapy 43, S54, Turkey, 01 November 2021

Retrospective analysis of all patients single center experience

KELKİTLİ E., ARSLAN E., TURGUT M.
XIth Eurasian Hematology Oncology, Turkey, 14 October 2020, vol.42, pp.37-38

Extranodal marginal zone lymphoma of the ocular adnexa

GÜL A. N., AYDIN Ö., KELKİTLİ E., ATAY M. H., TURGUT M.
XIth Eurasian Hematology Oncology, Turkey, 21 - 24 October 2020

What is the role of the decrease in immunoglobulin level after the first cycle in patient with multiple myeloma?

GÖKER H., KELKİTLİ E., TURGUT M.
Lymphoma and Myeloma Congress, New York, United States Of America, 23 - 26 September 2019

Relaps/Refrakter Hodgkin Lenfomada Nivolumab: Çok Merkezli Türkiye Deneyimi Uzun Dönem Sonuçları

BEKÖZ H. S., ÖZBALAK M. M., KARADURMUŞ N., PAYDAŞ S., TÜRKER F. A., TOPTAŞ T., et al.
45. Ulusl Hematoloji Kongresi, Turkey, 30 October - 02 November 2019

TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARIN ÇOKMERKEZLİ TANISAL TARAMA ÇALIŞMASI

İLHAN O., NARLI ÖZDEMİR Z., ÖZET G., falay m., YENEREL M. N., TUĞLULAR A. T., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019

Leptospirozis tanılı hastalarda bir inflamasyon belirteci olarak solubl P-selektin seviyesi

USTAOĞLU M., TURGUT M.
5. Karadeniz Hematoloji Kongresi, Samsun, Turkey, 28 - 30 June 2019, pp.20-31

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY

FERHANOĞLU A. B., ÖZBALAK M. M., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., TÜRKER F. A., et al.
24th European Hematology Association, Amsterdam, Netherlands, 13 - 16 June 2019, vol.3, pp.567-568

Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Real-Life Experience.

FERHANOĞLU A. B., ÖZBALAK M. M., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., TÜRKER F. A., et al.
EHA24, 24th International Congress of European Hematology Association, Amsterdam, Netherlands, 13 - 16 June 2019

Polisitemia Veralı Türk Hastalarda Hidroksiüre kullanım patterni: Çok merkezli bir çalışma

BÜYÜKAŞIK Y., ALİ R., TURGUT M., SAYDAM G., YAVUZ A. S., ÜNAL A., et al.
44. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, vol.1, pp.188-189

Retrospective and multicenter analysis of efficacy and safety of ruxolitinib in 176 Turkish patient with myelofibrosis: updated data

SOYER N., ALİ R., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., et al.
9. International Eurasian Hematology Oncology Congress, 17 - 20 October 2018

Evaluation of autoimmune hemolytic anemia patients after splenectomy: single centre experience

TEKİN M. G., ATAY M. H., KELKİTLİ E., MELETLİ Ö., TURGUT M.
LEUKEMIA RESEARCH, İstanbul, Turkey, 17 - 20 October 2018, vol.73, pp.40-41

KEMiK İLİĞİNDE HEPATOSPLENİK T HÜCRELİ LENFOMA OLGUSU

GÜN S., YILDIZ L., TURGUT M., ÜNER A.
4. KARDENİZ HEMATOLOJİ SEMPOZYUMU, Turkey, 29 June - 01 July 2018

Mutation frequency, clinical and prognostic impact of calreticulin gene in patients with essential thrombocytosis and primary myelofibrosis

AYMELEK H. S., OĞUR M. G., ALTUNDAĞ E., ABUR Ü., ATAY M. H., TURGUT M.
European Human Genetics Conference 2018 Milan Itally, Milan, Italy, 16 - 19 June 2018

Does Asymptomatic D-Dimer Elevation Predict Thrombosis in Patient on Immunomodulatory Drugs in Multiple Myeloma: Real-Life Data

AYDIN M. S., YAZGAN S. C., ALADAĞ KARAKULAK E., Çiftçiler R., KELKİTLİ E., TURGUT M., et al.
23.th European Hematology Association Congress, Sweden, 14 - 17 June 2018

Posttransplant Ebstain-Barr viral load monitoring experience in a hematopoietic stem cell transplantation center

AYDIN M. S., Inkaya Çağkan a., ALADAĞ KARAKULAK E., çiftçiler R., TURGUT M., GÖKER H., et al.
23.th European Hematology Association Congress, Sweden, 14 - 17 June 2018

Risk Factors For Early Mortality in Multiple Myeloma With Different Survival Time Cut -Off Points: Real -Life Data

AYDIN M. S., ALADAĞ KARAKULAK E., Çiftçiler R., DEMİROĞLU H., GÖKER H., TURGUT M., et al.
23.th European Hematology Association Congress, Sweden, 14 - 17 June 2018

POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER

AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018

DOES ASYMPTOMATIC D-DIMER ELEVATION PREDICT THROMBOSIS IN PATIENTS ON IMMUNOMODULATORY DRUGS IN MULTIPLE MYELOMA: REAL-LIFE DATA

AYDIN M. S., YAZGAN S. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., KELKİTLİ E., TURGUT M., et al.
23rd Congress of EHA, Stockholm, Sweden, 14 - 17 June 2018

REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER TURKISH EXPERİENCE

SEVİNDİK Ö. G., PEHLİVAN M., TUĞLULAR A. T., SOLMAZ Ş. M., DOĞU M. H., YALNIZ F. F., et al.
American Society of Hematology Congress, Atlanta, United States Of America, 9 - 12 December 2017, vol.130, pp.5405

Real-world data in relapsed refractory myelopma patients treated with carfilzomib, a multicenter Turkish experience

SEVİNDİK Ö. G., PEHLİVAN M., TUĞLULAR A. T., solmaz ş. m., DOĞU M. H., YALNIZ F. F., et al.
AMERİKAN HEMATOLOJİ DERNEĞİ KONGRESİ, United States Of America, 9 - 12 December 2017, vol.130, pp.5405

Donor Lymphocyte Infusions: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.
LYMPHOMAMYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.48

Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.
LYMPHOMA AND MYELOMA 2017, New York, United States Of America, 26 - 28 November 2017, vol.1, pp.43-44

kronik myeloproliferatif neoplazili hastalarda ruksolitinib etkinlik ve güvenliği: çok merkezli ve geriye dönük çalışma

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.
43.ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017

TÜRKİYE’DE PAROKSİSMAL NOKTÜRNALHEMOGLOBİNÜRİDEN ŞÜPHELENİLEN HASTALARINSIKLIĞININ SAPTANMASINA YÖNELİK ÇALIŞMA

İLHAN O., ÖZET G., FALAY M., YENEREL M. N., TURGUT M., ÜNAL A., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 05 November 2017

KRONİK MYELOPROLİFERATİF NEOPLAZİLİ HASTALARDA RUKSOLİTİNİB ETKİNLİK VE GÜVENLİĞİ: ÇOK MERKEZLİ VE GERİYE DÖNÜK ÇALIŞMA.

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ A. F., AYDOĞDU İ., PİR A., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017

DAHA ÖNCE YOĞUN TEDAVİ ALMIŞ RELAPS/REFRAKTERMULTİPL MİYELOM HASTALARINDA DARATUMUMABINETKİLİLİK VE GÜVENLİLİĞİ

BEKSAÇ M., aydın y., GÖKER H., TURGUT M., kalayoğlu beşışık s., çağırgan s., et al.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017

Nüks veya Refrakter Hodgkin Lenfoma Hastalarında Nivolumab Kullanımı Türkiye Verileri

FERHANOĞLU B., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., TÜRKER A., TOPTAŞ T., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017

Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation

KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.
LYMPHOMA MYELOMA 2017, 26 - 28 October 2017

Donor Lymhocyte Infusion: Single Center Experience

KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.
LYMHOMA MYELOMA 2017, 26 - 28 October 2017

Efficacy and safety of Ruxolitinib in Turkish Patients with chronic myeloproliferatif neoplasms:A multicenter and retrospective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., yılmaz f., AYDOĞDU İ., PİR A., et al.
AHOS, 21 - 24 September 2017

Efficiacy and safety of ruxolitinib in Turkish patients with chronic myeloprolipherative neoplasms:A multicenter and retropective analysis

SOYER N., TURGUT M., HAZNEDAROĞLU İ. C., YILMAZ F., AYDOĞDU İ., PİR A., et al.
4th Aegean Hematology Oncology Symposium, 21 - 24 September 2017

REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH CARFILZOMIB, A MULTICENTER EXPERİENCE

SEVİNDİK Ö. G., SOLMAZ Ş. M., PEHLİVAN M., KABUKLU S. H., YALNIZ F. F., ÖZKOCAMAN V., et al.
6.INTERNATIONAL CONGRESS OF LEUKEMIA LYMPHOMA MYELOMA, Antalya, Turkey, 11 - 13 May 2017

REAL-WORLD DATA IN RELAPSED REFRACTORYMYELOMA PATIENTS TREATED WITH CARFILZOMIB,A MULTICENTER TURKISH EXPERIENCE

SEVİNDİK Ö. G., SOLMAZ Ş., PEHLİVAN M., KAVUKÇU S., YALNIZ F. F., ÖZKOCAMAN V., et al.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 May 2017

Real-world data in relapsed refractory myeloma patients with carfilzomib, a multicenter turkish experience

SEVİNDİK Ö. G., medeni solmaz ş., PEHLİVAN M., HACIOĞLU S., YALNIZ F. F., ÖZKOCAMAN V., et al.
6th International Congress on Leukemia-Lymphoma-Myeloma, 11 - 13 May 2017

Cilt lezyonları ile başvuran akut lösemi olgusu

ALAYVAZ ASLAN N., AYRANCI E., KELKİTLİ E., AKTİMUR S. H., meletli ö., ATAY M. H., et al.
2. Ulusal Kan ve Kemik İliği Nakli Kongresi, Cyprus (Kktc), 16 - 19 February 2017

Meme kanseri tedavisi sonrası gelişen akut promyelositik lösemi olgusu

KELKİTLİ E., ALAYVAZ ASLAN N., AKTİMUR S. H., meletli ö., YILMAZ B., ATAY M. H., et al.
2. Ulusal Kan ve Kemik İliği Nakli Kongresi, Cyprus (Kktc), 16 - 19 February 2017

Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi

ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
2. Hematolojik Onkoloji Kongresi, Cyprus (Kktc), 16 - 19 February 2017

Miyeloproliferatif Hastalıklar ve Alt Gruplarında JAK2 V617F Mutasyonunun Dağılımı Klinik ve Hematolojik Korelasyon

AYMELEK H. S., ABUR Ü., AKAR Ö. S., ALTUNDAĞ E., TURGUT M., KELKİTLİ E., et al.
12. Ulusal Tıbbi Genetik Kongresi / 5 - 9 Ekim 2016 / ÇEŞME, İZMİR, İzmir, Turkey, 5 - 09 October 2016

Myeloproliferatif Hastalıklar ve Alt Gruplarında, JAK2 Mutasyonunun Dağılımı, Klinik ve Hematolojik Korelasyon

AYMELEK H. S., ABUR Ü., AKAR Ö. S., ALTUNDAĞ E., TURGUT M., KELKİTLİ E., et al.
12. Ulusal Tıbbi Genetik Kongresi, İzmir, Turkey, 5 - 09 October 2016

Impact of fluorescent in situ hybridization (FISH) aberrations and CLLU1 expression on the prognosis of chronic lymphocytic leukemia (CLL)

ABUR Ü., OĞUR M. G., AKAR Ö. S., ALTUNDAĞ E., AYMELEK H. S., TURGUT M.
European Human Genetics Conference 2016, Barcelona, Spain, 21 - 24 May 2016

Impact of fluorescent in situ hyridization FISH aberrrations and cllu1 expression on the prognosis of chronic lymphocytic leukemia CLL

ABUR Ü., OĞUR M. G., AKAR Ö. S., ALTUNDAĞ E., AYMELEK H. S., TURGUT M.
EUROPEAN HUMAN GENETICS CONFERENCE, 21 - 24 May 2016

What is the role of the decrease in M-protein after the first cycle in patient with multiple myeloma?

Turgut M., Akyazi E., Kelkitli E., Atay M. H., Yilmaz B.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34 identifier

Trombotik Trombositopenik Purpura ile Presente Olan Prostat Kanseri Olgusu

ASLAN N. A., AKTİMUR S. H., YILMAZ B., KELKİTLİ E., ATAY M. H., TURGUT M.
1.Hematolojik İmmünoloji Kongresi, Turkey, 24 - 26 March 2016

Eozinofili ve Mandibulada Kitle ile Başvuran Multiple Myelom Olgusu

KELKİTLİ E., ASLAN N. A., ATAY M. H., TURGUT M.
2. Ege Hematoloji Onkoloji Kongresi, Turkey, 18 - 20 March 2016

MYELODISPLASTIK SENDROMLU HASTALARIN RETROSPEKTIF İNCELENMESI VE PROGNOSTIK SKORLAMA SISTEMLERI

BATMACI M., AKTİMUR S. H., AKKOYUNLU K., ATAY M. H., KELKİTLİ E., TURGUT M.
2. EGE HEMATOLOJİ ONKOLOJİ GÜNLERİ, Turkey, 18 - 20 March 2016

AKUT LÖSEMİ DE MLL GEN DÜZENSİZLİKLERİ VE 11 KROMOZOM İLİŞKİLİ TRANSLOKASYONLARIN PROGNOSTİK ETKİSİ

AYMELEK H. S., OĞUR M. G., ABUR Ü., AKAR Ö. S., ALTUNDAĞ E., YILDIRAN A., et al.
II.Hematolojik Genetik Sempozyumu 24-26 ŞUBAT İZMİR, İzmir, Turkey, 24 - 26 February 2016

Akut Lösemi de MLL Gen Düzensizlikleri ve 11. Kromozom İlişkili Translokasyonların Prognostik Etkisi

AYMELEK H. S., OĞUR M. G., ABUR Ü., AKAR Ö. S., ALTUNDAĞ E., YILDIRAN A., et al.
2. Hematolojik Genetik Sempozyumu, İzmir, Turkey, 24 - 26 February 2016

MYELOPROLİFERATİF HASTALIKLARDA RUXOLİTİNİB YOLUYLA FARMAKOLOJİK JAK STAT İNHİBİSYONU İLE İLİŞKİLİ VARİCELLA ZOSTER ENFEKSİYONU

AKTİMUR S. H., ASLAN N. A., MALKAN Ü., DEMİREL N., ATAY M. H., KELKİTLİ E., et al.
3. Hematolojik Onkoloji ve Kemik İliği Transplantasyonu Sempozyumu, Turkey, 4 - 07 February 2016

BEYİNPARANKİM TUTULUMU SAPTANANSAÇLI HÜCRELİ LÖSEMİ OLGUSU

ASLAN N. A., AKTİMUR S. H., AKKOYUNLU K., KELKİTLİ E., ATAY M. H., TURGUT M.
3. Hematoloji Onkoloji ve Kemik İliği Transplantasyonu Sempozyumu, Turkey, 4 - 07 February 2016

An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)

Younes A., Salles G., Martinelli G., Bociek R. G., Barrigon D. C., Gonzalez Barca E., et al.
57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 5 - 08 December 2015, vol.126 identifier

Diagnostic value of FDG PET CT in the diagnosis of Multiple Myeloma

CANBAZ TOSUN F., USTA Y., YAPICI O., TURGUT M.
EANM 2015, 16 - 18 October 2015

Which is ISS or R-ISS?

Ekiz K., Aktimur S. H., Alayvaz N., Kelkitli E., Atay M. H., Turgut M.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33 identifier

Preliminary Safety Results from the Phase IIIb GREEN Study of Obinutuzumab (GA101) Alone or in Combination with Chemotherapy for Previously Untreated or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Bosch F., Illmer T., Turgut M., Cortelezzi A., Lasserre S. F., Truppel-Hartmann A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124 identifier

Kadın cinsiyet hormonu kullanımı ile ilgili papilloflebit olgusu

EŞKİ YÜCEL Ö., GÜNGÖR İ., GÜL A., TURGUT M., ARITÜRK N.
Türk Oftalmoloji Derneği 48.Ulusal Kongresi, Antalya, Turkey, 5 - 09 November 2014

The prognostic value of body mass index in Hodgkin lymphoma and diffuse non-Hodgkin lymphoma.

Turgut M., Kelkitli E., Atay M. H., Cilingir F. M., Yilmaz B.
50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 30 May - 03 June 2014, vol.32 identifier

Attention Prolonged prothrombin tıme

KELKİTLİ E., ATAY M. H., TURGUT M.
IV. Uluslararası Avrasya Hematoloji Kongresi, Antalya, Turkey, 9 - 13 October 2013, pp.114

KLL Tanılı Hastaların Moleküler Sitogenetik (FISH) Analiz Sonuçları ve Prognoza Olan Etkisi: Tek Merkezden 85 Hastanın Verileri

ABUR Ü., OĞUR M. G., KELKİTLİ E., AYMELEK H. S., GÜLER N., ALTUNDAĞ E., et al.
10. Ulusal Tıbbi Genetik Kongresi, Bursa, Turkey, 19 - 23 December 2012

Sheehan sendromu ve primer troid lenfoması birlikteliği

KUT E., KELKİTLİ E., ATAY M. H., BÜYÜKKAYA P., TURGUT M.
XXXVIII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.201

Dikkat kemik iliği aspirasyonu epilepsiyi tetikleyebilir

KELKİTLİ E., ATAY M. H., BÜYÜKKAYA P., GÜLER N., ÖZATLI D., TURGUT M.
XXXVIII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.273

Eltrombopag tedavisi ve tromboembolik komplikasyon gelişimi

KUT E., ÇİLİNGİR M. F., KELKİTLİ E., ATAY M. H., BÜYÜKKAYA P., TURGUT M.
XIV. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 3 - 06 October 2012, pp.271

Variant fusion signals detected by fish analysis in CML patients Do they indicate poor prognosis

OĞUR M. G., ekici f., ATAY M. H., KELKİTLİ E., ABUR Ü., ÖZATLI D., et al.
NEW FRONilERS IN MYELOID MALIGNANCIESTARGETED THERAPIES, CLINICAL STRATEGIESEUROPEAN LEUKEMİA NET, Berlin, Germany, 7 - 09 October 2011

T lenfoma hastalarında tanı anındaki mpv nötrofil lenfosit oranların sağ kalım üzerindeki etkisinin retrospektif olarak incelenmesi

ÇİLİNGİR M. F., KELKİTLİ E., ATAY M. H., TURGUT M.
15. ULUSAL İÇ HASTALIKLARI KONGRESİ, Antalya, Turkey, 2 - 05 October 2013, pp.157

Multipl myeloma hastalarında moleküler sitogenetik fısh ve sitogenetik analiz sonuçları Tek merkezden 106 hastanın verileri

OĞUR M. G., EKİCİ F., ATAY M. H., DURU F., ABUR Ü., TURGUT M.
XXXVI. Ulusal Hematoloji Kongresi, Antalya, Turkey, 3 - 07 November 2010, pp.51

Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy

BEKTAŞ A., ÇAKAR B., USTAOĞLU M., TURGUT M., BAKIR T.
5th APASL Single Topic Conference, İstanbul, Turkey, 17 - 20 May 2009, pp.120-121

Demir eksikliği anemisinde duodenal biyopsinin önemi

USTAOĞLU M., BAKIR T., BEKTAŞ A., TURGUT M., KAYA T., KARABİBER A. H.
4. Hepato Gastroenteroloji Kongresi, Antalya, Turkey, 1 - 05 September 2007, pp.359

Sitomegalovirüs enfeksiyonuna bağlı hepatit: Olgu sunumu

USTAOĞLU M., BEKTAŞ A., BAKIR T., TURGUT M., KARABİBER A. H.
4. Hepato Gastroenteroloji Kongresi, Antalya, Turkey, 01 September 2007, pp.315

Ebstein-Barr virüsüne bağlı kolestatik hepatit: Olgu sunumu

USTAOĞLU M., BAKIR T., BEKTAŞ A., TURGUT M.
3. Hepato Gastroenteroloji Kongresi, Antalya, Turkey, 02 September 2006, pp.188

Bıldırcın eti tüketimine bağlı rabdomiyoliz

TURGUT M., KARAOĞLANOĞLU M., YILMAZ B., YILDIRIM H., DİLEK M., ARIK N.
6. Ulusal İç Hastalıkları Kongresi., Turkey, 14 - 19 September 2004

Talasemi majör hastalarında doku doppler bulguları ve serum ferritin düzeyleri ile ilişkisi

DEMİRCAN S., YILMAZ B., KELKİTLİ E., UĞUR G., ŞAHBAT E., NESLİOĞLU E., et al.
5. Ulusal İç Hastalıkları Kongresi, Turkey, 26 - 30 September 2003

Sağlık personelinde hepatit B profilaksisinin önemi

KELKİTLİ E., YILMAZ B., NESLİOĞLU E., KARAOĞLANOĞLU M., USTAOĞLU M., TURGUT M., et al.
5. Ulusal İç Hastalıkları Kongresi, Turkey, 26 - 30 September 2003

Fludarabin ve rituximab ile uzun süreli remisyon elde edilen konvansiyonel tedaviye dirençli splenik marjinal zon lenfoma vakası

TURGUT M., YILMAZ B., KELKİTLİ E., KARAOĞLANOĞLU M., DOĞAN İ. Ö.
Türk Hematoloji Derneği 29. Ulusal kongresi, Turkey, 25 - 28 October 2002

Trombotik trombositopenik purpura ile prezante olan gastrointestinal kanser vakası

TURGUT M., GÖKSU U. A., YILMAZ B., KELKİTLİ E., USTAOĞLU M., YÜCEL İ.
4.Ulusal İç Hastalıkları Kongresi, Turkey, 25 - 29 September 2002
Books & Book Chapters

Castleman Hastalığı Epidemiyolojisi

KELKİTLİ E., TURGUT M.
in: Castleman Hastalığı, Kelkitli Engin, Editor, Ortadoğu Reklam Tanıtım yayıncılık Turizm Eğitim İnŞaat Sanayi ve Ticaret A.Ş, pp.1-3, 2023

Antikoagülan Tedavi

AKTİMUR S. H., TURGUT M.
in: Yoğun Bakım Ve Sorunları, ŞAHİNOĞLU Ali Haydar, Editor, Güneş Tıp Kitapevleri, pp.1460-1466, 2020

Edinsel Kanama Bozuklukları

TURGUT M., KELKİTLİ E.
in: ACİL TIP, CANDER BAŞER, Editor, İstanbul Tıp Kitapevleri, pp.1411-1416, 2020

Hematolojik Sistem ve Sorunları

ATAY M. H., TURGUT M.
in: Yoğun Bakım Sorunları ve Tedavileri, ALİ hAYDAR ŞAHİNOĞLU, Editor, gNÜŞ KİTABEBLERİ, Samsun, pp.1446-1452, 2020

Ediğnsel Kanama Bozuklukları

TURGUT M., KELKİTLİ E.
in: Acil TIP, CANDER BAŞER, Editor, İstanbul Tıp Kitapevleri, pp.1411-1416, 2020

Kan Ürünleri ile Tedavi Ve Transfüzyon Reaksiyonları

KELKİTLİ E., TURGUT M.
in: Yoğun Bakım Sorunları ve Tedavileri, Şahinoğlu Haydar, Editor, Güneş Tıp Kitabevi, pp.1436-1446, 2020

Klinik Pratikte Hematoloji

HAZNEDAROĞLU İ. C., TURGUT M., GÖKER H., BÜYÜKAŞIK Y.
nobel tıp kitabevleri, Ankara, 2019

Multipl Miyelomda Yeni İlaçlar ve Klinik Çalışmalar

KELKİTLİ E., TURGUT M.
in: Turkiye Klinikleri Hematology-Special Topics Multiple Myeloma, Hakan Göker, Editor, Türkiye Klinikleri (Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.), pp.59-64, 2019

Multipl Miyelomda Prognostik Faktörler ve Yeni Uluslararası Evreleme Sistemi

Aydın Ö., KELKİTLİ E., TURGUT M.
in: Turkiye Klinikleri Hematology-Special Topics Multiple Myeloma, , Editor, Türkiye Klinikleri (Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.), pp.1-4, 2019

Multipl Miyelom Epidemiyolojisi ve Genetiği, Tanısı ve Tedaviye Yanıt Kriterleri

MELETLİ Ö., KELKİTLİ E., TURGUT M.
in: Turkiye Klinikleri Hematology-Special Topics Multiple Myeloma, Hakan Göker, Editor, Türkiye Klinikleri (Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.), pp.21-24, 2019

Ondokuz Mayıs Üniversitesi Dasatinib Deneyimi

KELKİTLİ E., TURGUT M.
Sigma Publishing, 2018

Edinsel Kanama Bozuklukları

TURGUT M., KELKİTLİ E.
in: Acil Dahiliye, Cander Başar, Editor, İstanbul Tıp Kitabevi, pp.975-982, 2017

Edinsel Kanama Bozuklukları

TURGUT M., KELKİTLİ E.
in: Acil Tıp, Başar Cander, Editor, İstanbul Tıp Kitabevleri, pp.1295-1302, 2016

Kan Ürünleri ile Yedavi ve Transfüzyon Reaksiyonları

KELKİTLİ E., TURGUT M.
in: Yoğun Bakım Sorunları ve Tedavileri, A.Haydar Şahinoğlu, Editor, Nobel Tıp Kitapevleri, pp.1499-1508, 2011
Metrics

Publication

189

Citation (WoS)

964

H-Index (WoS)

14

Citation (Scopus)

791

H-Index (Scopus)

11

Citation (Scholar)

125

H-Index (Scholar)

3

Citiation (TrDizin)

2

H-Index (TrDizin)

1

Citiation (Sum Other)

3

Project

15

Open Access

28
UN Sustainable Development Goals